SMART Design to Compare Antipsychotic Treatments in Treatment-Resistant Schizophrenia
Status:
Not yet recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
The project intends to take treatment-resistant schizophrenia as the research object and uses
sequential multiple assignment randomized trial(SMART) design to define the treatment
recommendations of different drug regimen for treatment resistant schizophrenia and to
determine the physical enhancement regimen for clozapine-resistant schizophrenia and to
explore targeted regulation scheme for ultra-resistant schizophrenia.